Literature DB >> 12005219

Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS).

Michael Deters1, Gabriele Kirchner, Klaus Resch, Volkhard Kaever.   

Abstract

We developed a universal liquid chromatography-mass spectrometry (LC-MS) assay with automated online extraction to quantify simultaneously the immunosuppressants sirolimus, everolimus, tacrolimus, and cyclosporine. Whole blood (300 microl) plus 6 microl 32-desmethoxyrapamycin (1 ng/microl) as internal standard was treated with 600 microl methanol/0.2 M ZnSO4 (80/20 v/v). After vortexing (30 s) and centrifugation (20000 g, 5 min) 50 microl of the supernatant were loaded on an extraction column, were washed by 0.35 ml/min water for 3 min and, after activation of a column-switching valve, were back-flushed by 0.25 ml/min methanol/ water (90/10 v/v) onto a C18 analytical column. After 22 min the extraction column was washed for 2 min with methanol and for 3 min with water before starting the next run. Column temperatures were kept at 33 degrees C. Sodium adduct ions [M+Na]+ ions were detected in the selected ion mode. For sirolimus, everolimus and tacrolimus the assay was linear from 0.3 to 200 microg/l and for cyclosporine from 5 to 1000 microg/l (all r2>0.999). Recovery of all immunosuppressants and the internal standard was >90% and in general, inter-day and intraday precision was <10%. The simultaneous quantification of blood levels by LC-MS seems to be the method of choice in transplanted patients receiving multiple immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005219     DOI: 10.1515/CCLM.2002.045

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  12 in total

Review 1.  Therapeutic drug monitoring in pediatric renal transplantation.

Authors:  Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2014-04-25       Impact factor: 3.714

2.  Rapid estimation of whole blood everolimus concentrations using architect sirolimus immunoassay and mathematical equations: comparison with everolimus values determined by liquid chromatography/mass spectrometry.

Authors:  Amitava Dasgupta; Vanessa Moreno; Shawn Balark; Andre Smith; Marilyn Sonilal; Neelam Tejpal; Charles T Van Buren
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 3.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

4.  Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin.

Authors:  Jaime A Yáñez; M Laird Forrest; Yusuke Ohgami; Glen S Kwon; Neal M Davies
Journal:  Cancer Chemother Pharmacol       Date:  2007-03-29       Impact factor: 3.333

5.  A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors:  Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

6.  Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rats.

Authors:  Michael Deters; Gabriele Kirchner; Therese Koal; Klaus Resch; Volkhard Kaever
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

Review 7.  Clinical pharmacokinetics of everolimus.

Authors:  Gabriele I Kirchner; Ivo Meier-Wiedenbach; Michael P Manns
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs.

Authors:  Jeanne C Larson; Sara D Allstadt; Timothy M Fan; Chand Khanna; Paul J Lunghofer; Ryan J Hansen; Daniel L Gustafson; Alfred M Legendre; Gina D Galyon; Amy K LeBlanc; Tomas Martin-Jimenez
Journal:  Am J Vet Res       Date:  2016-01       Impact factor: 1.156

9.  Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS.

Authors:  Mustafa Karapirli; Murat Kizilgun; Ozgur Yesilyurt; Husamettin Gul; Zeki Ilker Kunak; Emin Ozgur Akgul; Enis Macit; Tuncer Cayci; Yasemin Gulcan Kurt; Ibrahim Aydin; Hakan Yaren; Melik Seyrek; Erdinc Cakir; Halil Yaman
Journal:  ScientificWorldJournal       Date:  2012-05-02

10.  mTOR Inhibitors in Tuberous Sclerosis Complex.

Authors:  Paolo Curatolo; Romina Moavero
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.